#UK Bioinformatics Market Share | Explore Tumblr Posts and Blogs

credenceresearchdotblog · 4 days

Text

The Human Genetics Market is projected to grow from USD 28665 million in 2024 to an estimated USD 59681.04 million by 2032, with a compound annual growth rate (CAGR) of 9.6% from 2024 to 2032.The human genetics market is experiencing rapid growth, driven by advancements in genomics, precision medicine, and the increasing understanding of the human genome's role in health and disease. The field of human genetics involves the study of genes, genetic variation, and heredity in humans, and its applications have far-reaching implications in healthcare, diagnostics, drug development, and personalized medicine. In this article, we will explore the current trends, key drivers, challenges, and future prospects of the human genetics market.

Browse the full report at https://www.credenceresearch.com/report/human-genetics-market

Overview of the Human Genetics Market

The global human genetics market has witnessed significant expansion in recent years, with the development of novel technologies such as next-generation sequencing (NGS), gene editing tools like CRISPR-Cas9, and advancements in bioinformatics. These technologies have made it possible to analyze genetic data more efficiently and accurately, providing valuable insights into disease mechanisms, inheritance patterns, and individual susceptibility to various health conditions. The market encompasses a wide range of products and services, including genetic testing, genome sequencing, gene therapy, pharmacogenomics, and molecular diagnostics.

Key Market Drivers

1. Rising Demand for Genetic Testing: Genetic testing has become a cornerstone in modern healthcare, enabling early detection and diagnosis of genetic disorders. It plays a crucial role in identifying genetic predispositions to conditions such as cancer, cardiovascular diseases, and neurological disorders. As awareness about genetic testing grows among both patients and healthcare providers, the demand for such tests is expected to rise. Moreover, direct-to-consumer (DTC) genetic testing services have gained popularity, allowing individuals to explore their genetic makeup and ancestry.

2. Precision Medicine Initiatives: The growing emphasis on precision medicine is a major driver of the human genetics market. Precision medicine aims to tailor medical treatments to individual patients based on their genetic, environmental, and lifestyle factors. By using genetic information to guide treatment decisions, healthcare providers can improve patient outcomes and reduce adverse drug reactions. As pharmaceutical companies invest in genomics-driven drug development, the demand for genetic research and testing is expected to surge.

3. Advances in Genomic Technologies: Technological advancements in genomics, particularly NGS, have revolutionized the way researchers and clinicians study the human genome. NGS allows for the rapid sequencing of entire genomes or specific genetic regions at a fraction of the cost of traditional methods. This has made large-scale genomic studies feasible and has paved the way for the identification of rare genetic variants associated with complex diseases. Additionally, gene editing technologies like CRISPR-Cas9 have opened new avenues for gene therapy and the correction of genetic mutations.

4. Government and Private Funding: Governments and private organizations worldwide are investing heavily in genomics research and healthcare innovations. For instance, initiatives like the U.S. National Institutes of Health’s (NIH) All of Us Research Program and the UK Biobank project are aimed at collecting large-scale genetic data to better understand the interplay between genetics and disease. These projects are expected to provide valuable resources for the development of new diagnostic tools and therapies.

Challenges Facing the Market

While the human genetics market holds tremendous promise, it is not without its challenges:

1. Ethical and Privacy Concerns: As genetic testing becomes more widespread, concerns over the privacy and security of genetic data are mounting. The potential misuse of genetic information by insurers, employers, or other third parties has raised ethical questions. Ensuring robust data protection measures and addressing ethical concerns are critical to maintaining public trust in genetic services.

2. High Costs of Genetic Testing and Therapies: Despite the declining cost of genome sequencing, genetic testing and gene therapies remain expensive for many patients. The high costs of these services, along with limited reimbursement from insurance providers, can hinder widespread adoption, particularly in low- and middle-income countries.

3. Regulatory Hurdles: The human genetics market is subject to stringent regulatory oversight, particularly for gene-editing technologies and gene therapies. Navigating complex regulatory frameworks and gaining approval for new genetic products can be a lengthy and costly process.

Future Prospects

The future of the human genetics market is bright, with several key trends poised to drive growth in the coming years:

1. Expansion of Personalized Medicine: The continued integration of genetic data into clinical practice will accelerate the shift towards personalized medicine. As researchers gain a deeper understanding of how genetics influence drug response, personalized treatment plans will become more prevalent, improving patient outcomes and reducing healthcare costs.

2. Emergence of AI and Machine Learning: The integration of artificial intelligence (AI) and machine learning into genomics research is expected to revolutionize data analysis. These technologies can analyze vast amounts of genetic data more efficiently, identifying patterns and correlations that may not be apparent through traditional methods. This will enhance our ability to predict disease risk and develop targeted therapies.

3. Increased Accessibility of Genetic Testing: As the cost of genomic technologies continues to decline, genetic testing will become more accessible to a broader population. This will allow for earlier disease detection, improved preventive care, and more targeted treatments, ultimately reducing the burden of genetic disorders.

Key Player Analysis:

Agilent Technologies,

Atrys Health (Spain)

Myriad Genetics,

Biomarker Technology (US)

biorad laboratories,

Bode technology,

Echevarne Laboratory (Spain)

Elabscience Biotechnology Inc (US)

Eurofins Megalab S.A (Spain)

FullGenomics (Spain)

GE healthcare,

GENinCode (UK)

Illumina,

LabCorp,

LGS Forensic,

Myriad Genetics (US)

NIMGenetics (Spain)

Orchid Cellmark,

Promega,

QIAGEN,

Sistemas Genómicos (Spain)

Synlab Group (Germany)

Thermo Fisher Scientific,

Segmentation:

By Type:

Genetic testing,

Genetic analysis,

Genetic research services.

By End User:

Hospitals and clinics,

Research and academic institutions,

Pharmaceutical and biotechnology companies.

By Region:

North America

The U.S

Canada

Mexico

Europe

Germany

France

The U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/human-genetics-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: [email protected]

Website: www.credenceresearch.com

0 notes

kathansky · 15 days

Text

Biotechnology Market is growing at a CAGR of 13.9% during the forecast period 2024-2031

Leading market research firm SkyQuest Technology Group recently released a study titled 'Biotechnology Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Biotechnology report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Biotechnology Market extensively demonstrates existing and upcoming opportunities, profitability, revenue growth rates, pricing, and scenarios for recent industry analysis.

The research analysis on the global Biotechnology Market report 2024 offers a close watch on top industry rivals along with briefings on their company profiles, strategical surveys, micro as well as macro industry trends, futuristic scenarios, analysis of pricing structure, and an all-encompassing overview of the Biotechnology Market circumstances in the forecast period between 2024 and 2031. The global Biotechnology Market is a dynamic and rapidly evolving sector, encompassing the development, production, and distribution. This market is essential for improving global market and driving economic growth through innovation and industry advancements. Market Growth The Biotechnology Market has experienced robust growth over the past decade and is projected to continue expanding. Biotechnology Market size was valued at USD 1.21 Trillion in 2022 and is poised to grow from USD 1.38 Trillion in 2023 to USD 3.90 Trillion by 2031, growing at a CAGR of 13.9% during the forecast period (2024-2031). This growth is driven by several factors, including an aging global population, increasing prevalence of advancements in technology, and rising global expenditure.

Chance to get a free sample @ https://www.skyquestt.com/sample-request/biotechnology-market

Detailed Segmentation and Classification of the report (Market Size and Forecast - 2031, Y-o-Y growth rate, and CAGR): The Biotechnology Market can be segmented based on several factors, including product type, application, end-user, and distribution channel. Understanding these segments is crucial for companies looking to target specific markets and tailor their offerings to meet consumer needs.

Type

Blue Biotechnology, Green Biotechnology, Red Biotechnology, White Biotechnology, Others

Product

Instrument & Reagent (Clinical Diagnostics, Proteomics and genomics, Drug Discovery & Development, Cell Analysis, Others), Software & Service

Technology

Nanobiotechnology, PCR Technology, Bioinformatics, Tissue Engineering, DNA sequencing, Fermentation Technology, Others

Application

Health, Agriculture, Food and Beverages, Industrial Processing, Others

Regional Analysis: On the basis of region, the market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The Biotechnology Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

Get your customized report @ https://www.skyquestt.com/speak-with-analyst/biotechnology-market

Following are the players analyzed in the report:

Biotechnology Market Top Player's Company Profiles

AstraZeneca (UK)

Gilead Sciences, Inc. (US)

Biogen Inc. (US)

Merck (Germany)

Illumina, Inc. (US)

Novo Nordisk A/S (Denmark)

Thermo Fisher Scientific Inc. (US)

Agilent Technologies, Inc. (US)

Lonza Group AG (Switzerland)

Pfizer Inc. (US)

Bristol-Myers Squibb (US)

Amgen Inc. (US)

AbbVie Inc. (US)

Regeneron Pharmaceuticals, Inc. (US)

Vertex Pharmaceuticals Incorporated (US)

Roche Holding AG (Switzerland)

Johnson & Johnson Services, Inc. (US)

Moderna, Inc. (US)

Bio-Rad Laboratories, Inc. (US)

Qiagen N.V. (Netherlands)

Regional Analysis 1. North America: - The United States and Canada dominate the North American Biotechnology Market. The U.S. is the largest market globally, driven by advanced global infrastructure, high R&D investments, and significant Biotechnology consumption. 2. Europe: - Europe is a significant player, with major Biotechnology Markets in Germany, France, and the United Kingdom. The region benefits from strong regulatory frameworks, high industry standards, and a robust R&D sector. 3. Asia-Pacific: - This region is experiencing rapid growth, with countries like China and India leading the charge. Factors such as increasing industry access, growing middle-class populations, and expanding Biotechnology manufacturing capabilities contribute to this growth. 4. Latin America: - Brazil and Mexico are key markets in Latin America. Growth in this region is driven by rising industry needs, increasing investments in industry infrastructure, and a growing demand for affordable medications. 5. Middle East and Africa: - The Biotechnology Market in this region is expanding due to rising market spending, increased prevalence of diseases, and improvements in Market infrastructure, although the market is relatively smaller compared to other regions. Future Outlook The Biotechnology Market is poised for continued growth driven by technological advancements, expanding global market access, and increasing global industry needs. As the industry adapts to evolving challenges and seizes emerging opportunities, it is likely to see ongoing innovation and expansion, contributing significantly to global health and economic development. Buy your full report: https://www.skyquestt.com/buy-now/biotechnology-market

#healthcare #health and wellness #health & fitness #healthylifestyle #health

0 notes

healthcaremarketresearchsblog · 3 months

Text

Biotechnology Market Growth and Status Explored in a New Research Report

The Insight Partners recently announced the release of the market research titled Biotechnology Market Outlook to 2031 | Share, Size, and Growth. The report is a stop solution for companies operating in the Biotechnology market. The report involves details on key segments, market players, precise market revenue statistics, and a roadmap that assists companies in advancing their offerings and preparing for the upcoming decade. Listing out the opportunities in the market, this report intends to prepare businesses for the market dynamics in an estimated period.

Is Investing in the Market Research Worth It?

Some businesses are just lucky to manage their performance without opting for market research, but these incidences are rare. Having information on longer sample sizes helps companies to eliminate bias and assumptions. As a result, entrepreneurs can make better decisions from the outset. Biotechnology Market report allows business to reduce their risks by offering a closer picture of consumer behavior, competition landscape, leading tactics, and risk management.

A trusted market researcher can guide you to not only avoid pitfalls but also help you devise production, marketing, and distribution tactics. With the right research methodologies, The Insight Partners is helping brands unlock revenue opportunities in the Biotechnology market.

If your business falls under any of these categories – Manufacturer, Supplier, Retailer, or Distributor, this syndicated Biotechnology market research has all that you need.

What are Key Offerings Under this Biotechnology Market Research?

Global Biotechnology market summary, current and future Biotechnology market size

Market Competition in Terms of Key Market Players, their Revenue, and their Share

Economic Impact on the Industry

Production, Revenue (value), Price Trend

Cost Investigation and Consumer Insights

Industrial Chain, Raw Material Sourcing Strategy, and Downstream Buyers

Production, Revenue (Value) by Geographical Segmentation

Marketing Strategy Comprehension, Distributors and Traders

Global Biotechnology Market Forecast

Study on Market Research Factors

Who are the Major Market Players in the Biotechnology Market?

Biotechnology market is all set to accommodate more companies and is foreseen to intensify market competition in coming years. Companies focus on consistent new launches and regional expansion can be outlined as dominant tactics. Biotechnology market giants have widespread reach which has favored them with a wide consumer base and subsequently increased their Biotechnology market share.

Report Attributes

Details

Segmental Coverage

Technology

DNA Sequencing

Fermentation

Cell-Based Assay

Nanobiotechnology

Chromatography

PCR Technology

Tissue Engineering Regeneration

Other Technologies

and Application

Industrial Processing

Bioinformatics

Food & Agriculture

Health

Natural Resources & Environment

Other Applications

Regional and Country Coverage

North America (US, Canada, Mexico)

Europe (UK, Germany, France, Russia, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, Australia, Rest of APAC)

South / South & Central America (Brazil, Argentina, Rest of South/South & Central America)

Middle East & Africa (South Africa, Saudi Arabia, UAE, Rest of MEA)

Market Leaders and Key Company Profiles

Thermo Fisher Scientific Inc.

Merck KGaA

PerkinElmer, Inc.

Agilent Technologies, Inc.

F. Hoffmann-La Roche Ltd.

Danaher

QIAGEN

Bio-Rad Laboratories, Inc.

Illumina, Inc.

Other key companies

What are Perks for Buyers?

The research will guide you in decisions and technology trends to adopt in the projected period.

Take effective Biotechnology market growth decisions and stay ahead of competitors

Improve product/services and marketing strategies.

Unlock suitable market entry tactics and ways to sustain in the market

Knowing market players can help you in planning future mergers and acquisitions

Visual representation of data by our team makes it easier to interpret and present the data further to investors, and your other stakeholders.

Do We Offer Customized Insights? Yes, We Do!

The The Insight Partners offer customized insights based on the client’s requirements. The following are some customizations our clients frequently ask for:

The Biotechnology market report can be customized based on specific regions/countries as per the intention of the business

The report production was facilitated as per the need and following the expected time frame

Insights and chapters tailored as per your requirements.

Depending on the preferences we may also accommodate changes in the current scope.

Author’s Bio:

Sunil Jadhav

Senior Market Research Expert at The Insight Partners

0 notes

infinitiresearch · 10 months

Text

Bioinformatics Market| Global Industry Analysis, Market Size, Share, Trends, Analysis, Growth and Forecast, 2023 – 2027

Originally published on Technavio: Bioinformatics Market - North America, Europe, EMEA, APAC : US, Canada, China, Germany, UK - Forecast 2023-2027

### **Bioinformatics Market Research Report**

#### **1. Executive Summary**

- Overview of the Bioinformatics market. - Key findings and market trends. - Market growth prospects.

#### **2. Introduction**

- Definition and significance of bioinformatics. - Historical development and evolution in the life sciences and healthcare industries.

#### **3. Market Size and Forecast**

- Historical market size and growth. - Current market size and trends. - Future projections and factors influencing growth.

#### **4. Market Dynamics**

- Drivers of market growth (increased demand for personalized medicine, advancements in genomics and proteomics, rise in data-driven biology). - Challenges and obstacles (complexity of data analysis, data privacy concerns, integration with healthcare systems). - Opportunities for market expansion (growth in cloud-based bioinformatics solutions, applications in drug discovery and development).

#### **5. Segmentation**

- Types of bioinformatics solutions (genomic analysis, proteomic analysis, metabolomic analysis) and their market share. - Regional segmentation and market presence.

#### **6. Competitive Landscape**

- Major bioinformatics solution providers and their market share. - SWOT analysis of key companies. - Trends in collaborations, acquisitions, and technological innovations.

#### **7. Regulatory Environment**

- Overview of regulations affecting the bioinformatics industry. - Compliance challenges and opportunities.

#### **8. Genomic Data Analysis**

- Trends in genomic data analysis techniques. - Impact on precision medicine, diagnostics, and disease research.

#### **9. Drug Discovery and Development**

- Growth and trends in bioinformatics applications for drug discovery. - Impact on target identification, biomarker discovery, and clinical trial optimization.

#### **10. Clinical Bioinformatics**

- Trends in clinical bioinformatics for diagnostics and treatment decisions. - Applications in oncology, infectious diseases, and rare genetic disorders.

#### **11. Bioinformatics in Agriculture**

- Growth and trends in bioinformatics applications for agricultural genomics. - Impact on crop improvement, pest resistance, and food safety.

#### **12. Bioinformatics in Personalized Medicine**

- Trends in bioinformatics for personalized medicine. - Impact on treatment customization, patient outcomes, and healthcare efficiency.

#### **13. Data Security and Privacy**

- Trends in data security and privacy measures for bioinformatics. - Initiatives to safeguard patient and research data.

#### **14. Research and Development Initiatives**

- Ongoing research and development initiatives in bioinformatics. - Innovations in algorithms, software platforms, and computational methodologies.

#### **15. Case Studies**

- Successful implementations of bioinformatics solutions. - Challenges faced by researchers and organizations in the field.

#### **16. Future Outlook**

- Emerging trends in bioinformatics technology. - Anticipated changes in technology adoption and market dynamics.

To Learn deeper into this report , View Sample PDF

#### **17. Recommendations**

- Strategic recommendations for bioinformatics solution providers. - Areas for further research and development.

#### **18. Conclusion**

- Summarize key findings. - Concluding thoughts on the future of the Bioinformatics market.

For more information please contact.

0 notes

marketinsightshare · 2 years

Text

Cancer Biomarkers Market - Industry Analysis, Market Size, Share, Trends, Growth And Forecast 2022 - 2027

Cancer Biomarkers Market size is estimated to reach $25.2 billion by 2027, growing at a CAGR of 11.7% during the forecast period 2022-2027. Biomarkers fall under the category of biological molecules or genes which have their presence in blood and other body fluids. These naturally occurring characteristics are discovered using bioinformatics and play a significant role in finding and understanding diseases and their behaviors. For example, blood pressure, platelets count are biomarkers as they help in the diagnosis of leukemia. Moreover, predictive, and prognostic biomarkers assist doctors in the prescription of personalized medicines to patients which means patients don’t have to go through gratuitous treatments and medications. The cancer biomarkers market outlook is exceptionally enchanting as the prevalence of various types of cancer has heightened in recent years. Rapid growth in biomarkers-associated technologies is helping in the epidemiology of health complications like cancer. The growing prevalence of cancer worldwide, and proliferating health consciousness among people are factors set to drive the growth of the Cancer Biomarkers Industry for the period 2022-2027.

Report Coverage

The report: “Cancer Biomarkers Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Cancer Biomarkers Market.

By Biomolecule Type: Protein and Genetic Biomarkers. By Cancer Type: Colorectal cancer, Lung Cancer, Prostate cancer, Breast Cancer, Stomach Cancer, Throat Cancer, and others. By Application: Personalized/Modified medicine, Diagnosis, Novel Drug Research, and development. By Technology: Bioinformatics and Cytogenetics, Imaging, Omics, and others. By Geography: North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, and Rest of South America) and Rest of World (the Middle East and Africa).

Key Takeaways

For More Details on This Report - Request for Sample

Cancer Biomarkers Market Segment Analysis - By Application

The Cancer Biomarkers Market based on the application type can be further segmented into Personalized/Modified medicine, Diagnosis, Novel Drug Research, and development. The diagnosis and personalized medicines segment held the largest share in 2021. The growth is owing to augmenting the prevalence of cancer around the globe which has broadened peoples’ cognizance. Around 40-50% of cancers can be cured with ease if diagnosed at an early stage. Any sort of delay in diagnosis could be life-threatening and patients must bear the colossal cost of treatments. Moreover, this segment is estimated to be the fastest-growing segment with a CAGR of 12.4% over the forecast period 2022-2027. This growth is owing to the effectiveness of diagnostics techniques and personalized medicines in the treatment and recovery of patients. Personalized medicines aren’t part of hit-and-trial treatments. They are patient-specific therefore emphasize on prevention of disease. Moreover, they exempt a patient from the side effects of unnecessary treatments.

Cancer Biomarkers Market Segment Analysis - By Cancer Type

The Cancer Biomarkers Market based on cancer type can be further segmented into Colorectal Cancer, Lung Cancer, Prostate cancer, Breast Cancer, Stomach Cancer, Throat Cancer, and others. The breast cancer segment held the largest share in 2021. Breast cancer’s occurrence is more common than other forms such as prostate and stomach. Last year it claimed over 600,000 lives. Furthermore, it is more popular among the female population than men because female breast cells are always visible to estrogen and progesterone growth hormones. On another hand, frequent incidences of obesity in females have their fair share in the intensification of breast cancer cases. However, the magnitude of obesity prevalence varies from nation to nation. However, the lung cancer segment is estimated to be the fastest-growing segment with a CAGR of 12.7% over the forecast period 2022-2027. This growth is owing to an upsurge in trends of smoking and drinking alcohol among adults as well as teenagers. On another hand, worsening air quality in many countries like India, China, the US due to rapid industrialization and the growing automobile industry is another leading cause of lung cancer.

Cancer Biomarkers Market Segment Analysis - By Geography

The Cancer Biomarkers Market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America held the largest share with 41% of the overall market in 2021. The growth in this segment is owing to well-established healthcare infrastructure. The US and Canada are home to world-class research laboratories and hospitals such as Mayo clinic. Mayo Clinic was recently labeled as the world’s best hospital by a magazine Newsweek. Due to lower wait times, American cancer patients have higher survival rates than the rest of the world. Moreover, due to high salary offers the US always remains the first choice for professionals from around the world. Likewise, the high per capita income and living standards of Americans allow them to undergo various therapies and treatments. Furthermore, the US spends around $11,560 per person on Medi-care and has a healthcare budget of around $4 trillion which further stems from the R&D activities.

However, the Asia-Pacific segment is expected to offer lucrative growth opportunities to marketers. This growth is owing to the escalation in the number of geriatrics, innumerable flow of riches for the progress of healthcare facilities. Besides, the pollution situation in Asian nations like India, China, Pakistan is worsening day after day. Several Indian and Chinese cities have the worst air quality which is another leading cause of cancer prevalence.

Cancer Biomarkers Market Drivers

Soaring cancer cases worldwide is Anticipated to Boost Product Demand

The widespread prevalence of cancer is a major driver for the aforementioned market. According to a World Health Organization report, after heart problems, cancer is the biggest reason for deaths around the globe. Last year it claimed more than 10 million lives. Ascribing to an upsurge in smoking trends, pollution levels, poor ingestion habits the cancer is prevailing at high speed. In 2021 around 235,760 lung cancer cases were reported in the US. Moreover, every year over 130,000 people lose their lives due to lung cancer in the US. Not just in the US, its spread has been augmented in other parts of the world as the smoking percentage has reached around 19% worldwide.

Augmenting healthcare spending and disposable income of people is Expected to Boost Product Demand

Growing healthcare spending can be a big driver in the growth of the cancer biomarker market. Considering the soaring prevalence of health complications and virus attacks governments have started enlarging flows of hard cash in research work and other developments. For instance, currently, the US spends around 16% of GDP on the healthcare sector and the number is anticipated to surge in foreseeable future. Besides, with sky-rocketing exports of many developing countries, their GDP per capita income is also elevating. With a 10% hike, Bangladesh’s per capita income touched $2,227 in the financial year 2020-21. Therefore, with the expansion in disposable income, it becomes easy for people to spend on healthcare.

Cancer Biomarkers Market Challenges

The exorbitant cost of cancer diagnostic and treatment is Anticipated to Hamper Market Growth

Cancer treatments can cost a fortune which is the biggest challenge in front of cancer biomarkers. With growing success rates of cancer drugs, their prices are elevating also. The cost of cancer medications on monthly basis may cross $100,000 which the majority of the population can not afford to pay. Forget about poor and middle-class people even the rich struggles to fund the expenses of such extortionate treatments. The cost of medications can be 10-12 times what many people earn in a month. Consequently, it poses a serious setback in the growth of the respective market.

Cancer Biomarkers Market Competitive Landscape

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Cancer Biomarkers Market. Key companies of this market are-

Abbott Laboratories

Biomerieux

Thermo Fisher Scientific

Quest Diagnostics

Dickinson and Company

Roche Diagnostics

Agilent Technologies

Illumina

Qiagen

Affymetrix Inc.

Recent Developments

In January 2022, the University of Oxford has published in Clinical Cancer Research that a new type of blood test can be used to detect a range of cancers and whether these cancers have evenly spread throughout the body. The study had a sample size of 300 patients, with non-specific but concerning symptoms of cancer such as fatigue and weight loss. The following were recruited through the Oxfordshire Suspected Cancer Pathway. Results show that cancer was correctly detected in 19 out of every 20 patients with cancer using this test. In those with cancer, metastatic disease was identified with an overall accuracy of 94%.

In January 2022, Mainz Biomed N.V., a molecular genetics diagnostic company specializing in the early detection of cancer, announced today it has entered into a Technology Rights Agreement with Socpra Sciences Santé Et Humaines S.E.C. (“TTS”) to access a portfolio of novel mRNA biomarkers for potential future integration into ColoAlert, the Company’s highly efficacious, and easy-to-use detection test for colorectal cancer (“CRC”).

In January 2022, Nucleix has announced advancements in the early lung cancer detection program. Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, announced recent advances in its EpiCheck® Next Generation Sequencing (NGS) platform and lung cancer detection program for early-stage disease. The company also recently secured an additional $22 million in funding, as an extension to the previously announced $55 million financings, bringing the total capital raised in 2021 to $77 million, to rapidly advance the next generation of its highly sensitive lung cancer product and drive a multi-center prospective trial for clinical validation.

#Cancer Biomarkers Market share #Cancer Biomarkers Market size #Cancer Biomarkers Market forecast

0 notes

dbmrpune-blog · 5 years

Text

Bioinformatics Market | Trends | Forecast to 2026

Market Analysis: Global Bioinformatics Market

Global Bioinformatics Market is expected to reach USD 26.33 billion by 2026 from USD 7.76 billion in 2018, at a CAGR of 16.5% in the forecast period 2019 to 2026. The new market report contains data for historic years 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Looking for Sample Report?

Here you can - https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-bioinformatics-market

Market Definition: Global Bioinformatics Market

A science which is a combination of biology and information technology, connects biological data with techniques for storing information, distributing, and analyzing to support different areas of scientific research, including biomedicine known as Bioinformatics. It applies tools for database creation, data management, data warehousing, data mining, and others.

Key Market Competitors: Global Bioinformatics Market

Few of the major competitors currently working in the bioinformatics market are Thermo Fisher Scientific (US), Illumina Inc. (US), Agilent Technologies, Inc. (US), QIAGEN (Netherlands), BGI (China), Wuxi NextCODE (China), Eurofins Scientific (Luxembourg), Waters Corporation (US), Sophia Genetics (Switzerland), Partek (US), DNASTAR (US), Dassault Systèmes (France), DNAnexus, Inc. (US), Genebio (Switzerland), ASEBIO (Spain), PerkinElmer Inc. (US), abm Inc.(Canada) a few among others.

Request for TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-bioinformatics-market

Market Analysis: Global Bioinformatics Market

Market Definition: Global Bioinformatics Market

Market Drivers

· Increasing government initiatives and funding will drive the growth of the market.

· Growing use of bioinformatics in drug discovery and bio-markers development processes.

Market Restraints

· Shortage of trained research personnel required for proper use of bioinformatics toolsis expected to act as a restraint to the market growth.

· Non-availability of platforms to integrate large data sets produced by bioinformatics is expected to offset the growth of this market.

Segmentation: Global Bioinformatics Market

· By Product Type

o Sequencing platforms

o Sequence Analysis Platforms

o Sequence Alignment Platforms

o Sequence Manipulation Platforms

o Structural Analysis Platforms

o Others

o Knowledge management tools

o Generalized Knowledge Management Tools

o Specialized Knowledge Management Tool

o Bioinformatics software.

· By Industry

o Molecular medicine

o Drug development

o Clinical diagnostics

o Agriculture

o Forensic

o Animal

o Academics and research

o Environmental and gene therapy

· By Sector

o Medical biotechnology

o Drug discovery & development

o Clinical diagnostics & precision medicine

o Reproductive health

o Academics

o Animal biotechnology

o Agricultural biotechnology

o Environmental biotechnology

o Forensic biotechnology.

· By Applications

o Preventive medicine

o Molecular medicine

o Genomics & Drug development

o Chemoinformatics and drug design

o Proteomics

o Transcriptomics

o Metabolomics

o Transcriptomics

o Other biotechnological applications

· By Services

o Data integration

o Data analysis

o Structural

o Functional

o Sequencing

· By Geography

o North America

o US.

o Canada

o Mexico

o South America

o Brazil

o Argentina

o Rest of South America

o Europe

o Germany

o France

o United Kingdom

o Italy

o Spain

o Russia

o Turkey

o Belgium

o Netherlands

o Switzerland

o Rest of Europe

o Asia-Pacific

o Japan

o China

o South Korea

o India

o Australia

o Singapore

o Thailand

o Malaysia

o Indonesia

o Philippines

o Rest of Asia Pacific

o Middle East & Africa

o South Africa

o Egypt

o Saudi Arabia

o United Arab Emirates

o Israel

o Rest of Middle East & Africa

Key Developments in the Market:

· In April 2019, The HANS-GINS Indxx Healthcare Innovation Ucits ETF will focus on developments in sectors including bioinformatics, bioengineering, genome sequencing, healthcare trackers, nanotechnology, neuroscience, robotics and medical devices.

· In March 2017, Agilent Technologies Inc. introduced its first comparative genomic hybridization (CGH) assay which will be used for diagnostic purposes: the GenetiSureDx Postnatal Assay. This will help the clinical geneticists to detect genetic anomalies early with more accuracy as compared to than traditional methods.

Competitive Analysis: Global Bioinformatics Market

Global bioinformatics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of bioinformatics market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

· Current and future of bioinformatics market outlook in the developed and emerging markets

· The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period

· Regions/Countries that are expected to witness the fastest growth rates during the forecast period

· The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

· All segmentation provided above in this report is represented at country level

· All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

· About Us:

· Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

· Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing [email protected] . We are content with our glorious 99.9 % client satisfying rate.

· Contact:

· Data Bridge Market Research

· Tel: +1-888-387-2818

· Email: [email protected]

· Contact: Data Bridge Market Research US: +1 888 387 2818 UK: +44 208 089 1725 Hong Kong: +852 8192 7475 Email: [email protected]

Some Other Reports

Global industrial automation market

Global blockchain identity management market

1 note · View note

marketresearchindia · 2 years

Text

Global Genotyping Assay Market Growth Is Influenced By Increasing Incidence Of Genetic Diseases: Ken Research

Buy Now

According to the report analysis, ‘Global Genotyping Assay Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027’ states that Danaher, Roche, GE, Thermo Fisher Scientific, Agilent Technologies, Illumina, Bio-Rad Laboratories, Qiagen, Perkinelmer, Fluidigm, Brooks Automation (Genewiz), Eurofins Scientific, Pacific Biosciences of California and many more are the foremost companies which recently functioning in the global genotyping assay market more proficiently for ruling around the globe, registering the great value of market share, keep maintaining the governing position, leading the highest market growth, obtaining the competitive edge and generating the highest percentage of revenue by analysing the strategies and policies of government as well as contenders, establishing the several research and development programs, increasing the features and benefits of genotyping, spreading the awareness connected to the applications and advantages of genotyping assay, implementing the policies of profit making and strategies of expansion and improving the qualitative and quantitative measures of such.

The major aspects that are projected to be propelling the genotyping assay market are technological innovations and the reducing the prices of DNA sequencing. The growing incidence of genetic diseases and augmenting the awareness of personalized medicine, growing importance of genotyping in drug development, and the augmenting demand for bioinformatics solutions in data analysis are also projected to encourage the market growth in the coming years. The objective of the report is to define, describe, and review the genotyping assay market size reliant on product & service, technology, application, end user, and region.

Request For Sample Report-https://kenresearch.com/sample-report.php?Frmdetails=NDQ0NzA0

The growth can be accredited to technological innovations, the growing prevalence of cancer & genetic disorders, and augmenting the R&D funding for precision medicine research. Furthermore, the COVID-19 pandemic observed a positive impact on the genotyping market, as the pandemic led to an augmented demand for COVID-19 genotyping kits. SNP genotyping has been utilized for the detection of genetic variants of the Covid-19 virus.

The global genotyping assay market is influenced by a number of aspects. One among them is the increment in the number of genetic diseases all across the world. Following that is the general awareness concerning personalized medicine all around the globe especially in the developed regions of the world. Another imperative factor projected to boost the growth of the global genotyping assay market is the deduction in the cost of DNA sequencing along with other technological innovations. Besides, surge in the drug development and growing importance and awareness of drug development is also propelling the complete market.

The North American region is projected to dominate the complete market owing to the growing incidence of genetic diseases and immediate measures that are taken accordingly especially across the developed regions of Canada and the U.S. On the other hand, Europe is also seen to be augmenting in terms of enhanced healthcare and medical facilities and hence, the market in Europe and Asia Pacific is projected to augment during the forecast period on account of developing medical infrastructure across countries of UK, France and Germany in the European region and India, China, and Japan of the Asia Pacific region.

For More Details-

Global Genotyping Assay Market Research Report

Related Post-

2022-2027 Global and Regional Inhaled Nitric Oxide Industry Status and Prospects Professional Market Research Report Standard Version

2022-2027 Global and Regional Syringe and Needle Industry Status and Prospects Professional Market Research Report Standard Version

LinkedIn | Instagram | Facebook | Twitter | YouTube

Ken Research

Ankur Gupta, Head Marketing & Communications

[email protected]

+91-9015378249

0 notes

healthcareresearchboom · 2 years

Text

Bioinformatics Services Market Growth Prospect & Future Scenario by 2026

The bioinformatics services market is projected to reach USD 5.3 Billion by 2026 from USD 2.5 Billion in 2021, at a CAGR of 15.8% during the forecast period. Growing applications of bioinformatics across industries, increasing public-private sector funding for bioinformatics services, and the shortage of skilled bioinformatics professionals (leading to increased outsourcing of bioinformatics projects) are the major factors that are expected to drive the growth of the bioinformatics services market during the forecast period. However, the in-house development of bioinformatics solutions and publicly available bioinformatics tools are expected to limit market are expected to restrain market growth in the coming years.

Access Sample Copy of the Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=75889439

Based on application, the bioinformatics services market is segmented into genomics, chemoinformatics and drug design, proteomics, transcriptomics, metabolomics and other applications. Large share is attributed to genomics segment due to increasing use of pharmacogenomic research for the development of precision medicine, favorable funding scenario for genomic research, and partnerships and collaborations between various life sciences and informatics companies for the development of advanced bioinformatics solutions and services.

Based on type, the bioinformatics services market is segmented into sequencing services, data analysis, drug discovery services, differential gene expression analysis, database and management services, and other bioinformatics services. Due to reduced cost of sequencing the sequencing services segment enjoy the major share of the market.

Based on specialty, the bioinformatics services market is segmented into medical biotechnology, plant biotechnology, animal biotechnology, environment biotechnology and forensic biotechnology. Medical biotechnology holds the largest share due to the development of new databases for drug discovery, the use of bioinformatics for clinical diagnostics, and increasing funding for the development of bioinformatics solutions for clinical diagnostics.

Based on end-users, the bioinformatics services market has been segmented as —academic institiutes and research centers, hospitals and clinics, pharma and biotech companies, CROs and other end users. The large share of academic institutes and research centers segment can be attributed to the growing number of bioinformatics-based research studies, increasing scale of genomics research, rising number of collaborations between academic research institutes and players in the bioinformatics market, and the growing number of government funding programs for genomics research.

North America dominated the global bioinformatics services market in 2020

The North American market dominated the bioinformatics services market. The market growth in North America can be attributed to government initiatives for the reimbursement of genomic testing and favorable funding scenario for research activities.

Prominent players in the bioinformatics services market include Illumina (US), Thermo Fisher Scientific (US), Eurofins Scientific (Luxembourg), BGI Group (China), NeoGenomics (US), PerkinElmer (US), CD Genomics (US), Psomagen, Inc. (South Korea), QIAGEN (Germany), GENEWIZ (US), Source BioScience (UK), Microsynth (Switzerland), MedGenome (India), Fios Genomics (UK), and BaseClear (Netherlands), among others.

Download PDF Brochure: @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=75889439

Don’t miss out on business opportunities in Bioinformatics Services Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA : 1-888-600-6441 [email protected]

#Bioinformatics Services Market

0 notes

latest-market-insights · 3 years

Text

Synthetic Biology Market 2022 | Business Opportunity, Growth Strategies & Forecast Report By 2028

The Global Synthetic Biology Market Report, in its latest update, highlights the significant impacts and the recent strategical changes under the present socio-economic scenario. The Synthetic Biology industry growth avenues are deeply supported by exhaustive research by the top analysts of the industry. The report starts with the executive summary, followed by a value chain and marketing channels study. The report then estimates the CAGR and market revenue of the global and regional segments.

Base Year: 2021

Estimated Year: 2022

Forecast Till: 2023 to 2028

The report classifies the market into different segments based on type and product. These segments are studied in detail, incorporating the market estimates and forecasts at regional and country levels. The segment analysis is helpful in understanding the growth areas and potential opportunities of the market.

Get | Download FREE Sample Report of Global Synthetic Biology Market @ https://www.decisiondatabases.com/contact/download-sample-16712

A special section is dedicated to the analysis of the impact of the COVID-19 pandemic on the growth of the Synthetic Biology market. The impact is closely studied in terms of production, import, export, and supply.

The report covers the complete competitive landscape of the Worldwide Synthetic Biology market with company profiles of key players such as:

Amyris Inc.

DuPont

GenScript

Intrexon

Integrated DNA Technologies, Inc.

New England Biolabs

Novozymes

Koninklijke DSM N.V.

Synthetic Genomics Inc.

Thermo Fisher Scientific Inc.

Want to add more Company Profiles to the Report? Write your Customized Requirements to us @ https://www.decisiondatabases.com/contact/get-custom-research-16712

Synthetic Biology Market Analysis by Product:

Core Products

Enabling Products

Synthetic Biology Market Analysis by Technologies:

Genome Engineering

DNA Sequencing

Bioinformatics

Biological Components & Integrated Systems

Synthetic Biology Market Analysis by Applications:

Chemicals

Healthcare

Agriculture

Others (Biosecurity, R&D, Energy and Environment)

Synthetic Biology Market Analysis by Geography:

North America (USA, Canada, and Mexico)

Europe (Germany, UK, France, Italy, Russia, Spain, Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, Australia, South-East Asia, Rest of Asia-Pacific)

Latin America (Brazil, Argentina, Peru, Chile, Rest of Latin America)

The Middle East and Africa (Saudi Arabia, UAE, Israel, South Africa, Rest of the Middle East and Africa)

Key questions answered in the report:

What is the expected growth of the Synthetic Biology market between 2022 to 2028?

Which application and type segment holds the maximum share in the Global Synthetic Biology market?

Which regional Synthetic Biology market shows the highest growth CAGR between 2022 to 2028?

What are the opportunities and challenges currently faced by the Synthetic Biology market?

Who are the leading market players and what are their Strengths, Weakness, Opportunities, and Threats (SWOT)?

What business strategies are the competitors considering to stay in the Synthetic Biology market?

Purchase the Complete Global Synthetic Biology Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-16712

About Us:

DecisionDatabases.com is a global business research report provider, enriching decision-makers, and strategists with qualitative statistics. DecisionDatabases.com is proficient in providing syndicated research reports, customized research reports, company profiles, and industry databases across multiple domains. Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors. We provide intellectual, precise, and meaningful data at a lightning speed.

For more details: DecisionDatabases.com E-Mail: [email protected] Phone: +91 90 28 057900 Web: https://www.decisiondatabases.com/

#Synthetic Biology Market #Synthetic Biology Market Report #Synthetic Biology Market Size #Synthetic Biology Market Research Report

0 notes

rahulg1122 · 3 years

Text

Proteomics Market worth $55.9 billion by 2026

According to the new market research report "Proteomics Market by Product (Spectroscopy, Chromatography, Electrophoresis, X-ray Crystallography), Reagent, Service (Core Proteomics, Bioinformatics), Application (Diagnostic, Drug Discovery), End User (Hospital, Labs, Biopharma) - Global Forecast to 2026", published by MarketsandMarkets™, the Proteomics Market is valued at an estimated USD 25.9 billion in 2021 and is projected to reach USD 55.9 billion by 2026, at a CAGR of 16.6%.

Browse in-depth TOC on "Proteomics Market"

161 – Tables

47 – Figures

296 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=731

An increase in the research activity, especially in the area of personalized medicine and drug discovery, is the primary growth driver for this market. In addition, the increasing R&D expenditure by pharmaceutical and biotechnology companies, increasing government funding, and technological advancements are also propelling the market growth.

The core proteomics services segment accounted for the largest share of the proteomics market, by product segment, in 2020

Based on service and software, the market is segmented into core proteomics services and bioinformatics software & services. In 2020, the core proteomics services segment accounted for the largest share of the global market. Core proteomics services form the basis of proteomics and are highly adopted at every stage of proteome analysis.

Clinical Diagnostics segment to register the largest share during the forecast period

Based on applications, the proteomics market is segmented into drug discovery, clinical diagnostics, and other applications. In 2020, the clinical diagnostics segment accounted for the largest share of the market. This can be attributed to the increased understanding of the relevance of investigating and understanding patterns of protein expression for disease diagnostics and drug development.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=731

North America is the largest regional market for proteomics market

The global market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. In 2020, North America accounted for the largest market share. This can be attributed to the increasing investments in the development of structure-based drug design, growing research in the field of omics, rising demand for high-quality research tools for data reproducibility, and increasing focus on developing personalized therapeutics. The presence of a large number of global players in this region is also supporting the growth of this market

The major players operating in proteomics market are Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Bruker Corporation (US), Danaher Corporation (US), GE Healthcare (US), Luminex Corporation (US), PerkinElmer Inc. (US), Waters Corporation (US), Illumina, Inc. (US), Eurofins Scientific (Luxembourg), QIAGEN Bioinformatics (Netherlands), Creative Proteomics (US), Promega Corporation (US), Sengenics (Singapore), Biomax Informatics AG (Germany), MS Bioworks LLC (US), WuXi NextCODE (China), Fios Genomics Ltd. (UK), GENEWIZ (US), Biognosys AG (Switzerland), Bioproximity (Switzerland), MRM Proteomics Inc. (Canada), Integrated Proteomics Applications (US), Poochon Scientific, LLC (US), Proteome Factory AG (Germany), VProteomics (India), HORIBA, Ltd. (Japan), and Applied Biomics, Inc. (US).

#proteomics market

0 notes

vrushabhgugale · 3 years

Text

Next-Generation Sequencing Data Analysis Market Size, Share & Trends Analysis Report By Application Up To 2027

Next-Generation Sequencing Data Analysis Market Overview: The Maximize Market research report gives you a complete report of the global Next-Generation Sequencing Data Analysis Market. The study focuses on developing Market trends and important growth factors to assist Market participants in identifying opportunities in the Next-Generation Sequencing Data Analysis Market. The research provides a comprehensive overview of the Market, as well as Market financials such as Market size from 2015 to 2020, with 2020 as the base year and forecast years 2021-2027. The breadth and segments of the global Next-Generation Sequencing Data Analysis Market are covered in the Maximize Market Research report, which categorises it by product type, application areas, and geographies. The Market segmentation prioritises specific Markets and prospects over individual segments. North America, Europe, APAC, South America, and MEA are the major regions of the world included in the report. This provides a revenue forecast for each region from 2021 to 2027. COVID-19 Impact on Global Next-Generation Sequencing Data Analysis Market: Different racial and ethnic groups reacted differently to the COVID-19 dislike. Inequities in the social determinants of health, such as income and wealth, access to and use of health care, education, occupation, discrimination, and housing, are all linked. Economic headwinds will come from a variety of directions for emerging Market and developing nations. Even this grim prognosis is fraught with uncertainty and huge dangers to the negative. The pace with which the crisis has engulfed the global economy may provide insight into the depth of the recession. Our highly skilled and informed team is always innovating and delivering innovative solutions to our clients, all while utilising the most cutting-edge technologies.

Get Sample Report:https://www.maximizemarketresearch.com/request-sample/100220

The key manufacturers in the Next-Generation Sequencing Data Analysis Market  Thermo Fisher Scientific, Inc.  Illumina, Inc.  QIAGEN  F. Hoffman-La Roche Technologies  Agilent Technologies  Intrexon Bioinformatics Germany GmbH  Partek, Inc.  PierianDx  DNASTAR, Inc.  Eurofins Scientific  Congenica Ltd.  Bio Rad Laboratories, Inc.  Genuity Science  DNAnexus Inc.  SciGenom Labs Pvt. Ltd  Golden Helix, Inc.  Other Key Players

This Maximize Market research report shows the possible economic benefits of investing in the Next-Generation Sequencing Data Analysis Market to provide a greater understanding of the industry. Not only does the research provide a bright view for the Market, but it also analyses the drawbacks and risks that may arise for investment or competitiveness as a result of the emergence of some unfavourable aspects. The study's research analysts and industry speakers share their forecasts of the Next-Generation Sequencing Data Analysis industry. The goal of this Maximize Market Research report is to compile the opinions and recommendations of the industry leaders who were contacted throughout the research. Global Next-Generation Sequencing Data Analysis Market Regional Analysis Includes: • Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia) • Europe (Turkey, Germany, Russia UK, Italy, France, etc.) • North America (the United States, Mexico, and Canada.) • South America (Brazil etc.) • The Middle East and Africa (GCC Countries and Egypt.)

Read complete report along with TOC:https://www.maximizemarketresearch.com/market-report/next-generation-sequencing-data-analysis-market/100220/

The overall purpose of the Maximize Market research report is to determine Market priorities and bottlenecks. The paper also offers advice on how to best handle the risks posed by new and disruptive technologies. Most importantly, referring to this report assists Market participants in staying informed of changing Market dangers and providing the best advice possible to Market participants, as well as the introduction or amendment of regulatory processes. This Maximize Market Research report study contains results and suggestions tailored to all Market players, investors, stakeholders, and other participants in the global Next-Generation Sequencing Data Analysis Market. This Maximize Market research report will serve as a valuable resource for those looking to acquire a competitive advantage in the Market. Contact us: MAXIMIZE MARKET RESEARCH PVT. LTD. 3rd Floor, Navale IT park Phase 2, Pune Banglore Highway, Narhe,Pune, Maharashtra 411041, India. Email: [email protected] Phone No.: +91 20 6630 3320 Website: www.maximizeMarketresearch.com

#Next-Generation Sequencing Data Analysis

0 notes

newsupdate-1 · 3 years

Text

Biotechnology Market Latest Trends, Size And Forecast Analysis To 2027

The global biotechnology market is estimated to reach USD 727.12 billion by 2026 growing at a CAGR of 6.84% during the forecast period, according to a new study published by Polaris Market Research. The report ‘Biotechnology Market Share, Size, Trends & Industry Analysis Report, By Technology (Fermentation, Tissue Engineering and Regeneration, PCR Technology, Nanobiotechnology, Chromatography, DNA Sequencing, Cell Based AssaysOthers); By Application (BioPharmacy, BioServices, BioAgriculture, BioIndustrial, Bioinformatics); and By Regions: Segment Forecast, 2019 – 2026’ provides an extensive analysis of present market dynamics and predicted future trends.

Growing hepatitis B disease, increasing interest of horticultural items such as sugarcane, rice, beans, and wheat due from the increasing populations in economies such as U.S., China and India are expected to push the overall biotechnology market. The growth of this market is further propelled by elements such as deficiency of water, low yield of items, insect attacks, and constrained availability of agrarian land, which is promoting the companies to invest and conduct R&D activities at a broader scale. Another factor which is helping the market growth includes regenerative medicines. Existence of a huge section of businesses concentrating on the advancement of regenerative treatments is anticipated to push the market development through to 2026. Technological developments in the areas of artificial intelligence in this market is estimated to sustain progress with possible opportunities. The companies are engaged in using artificial intelligence in order to understand cancer cases, while working on the medical trials.

Get Sample copy of report: https://www.polarismarketresearch.com/industry-analysis/biotechnology-market/request-for-sample

Encouraging government policies associated with biological advancements is also propelling the growth in this market. Established economies such as United States and UK and growing economies such as China and India are investing in the biotechnology R&D initiatives. Governments are associating with private companies for expanding their research into this domain.

Owing to technological improvements and prevalent applications of biotechnology in healthcare is helping the market to gain a strong growth during the forecast period. Companies are constantly introducing brand-new biotechnological medicines and vaccines to deal with diagnosis and biopharmaceutical development within the healthcare sector, is approximated to push the market further towards its growth. Bioinformatics is anticipated to witness the fastest growth in the coming years. Developments in data combination tools through cloud computing platform facilitate analysis and assistance to process enormous next-generation sequencing information. These advancements are approximated to greatly boost adoption of bioinformatics tools in numerous life sciences applications in the near future. Application of nanotechnology-based products is anticipated to improve development in this sector. Reducing costs and increase in number of services related to biotechnology are expected to drive the market with profitable avenues.

North American pharma and biotech organizations have experienced excellent success in last couple of years resulting in a larger market share. Universities and research institutes are also introducing various biotech-based programs which would help the market to gain its much-required traction. The Asia Pacific market on the other hand is anticipated to grow at the most significant rate due to improving and growing healthcare infrastructure coupled with local companies in this region focusing on developing advanced medicines to cure chronic diseases such as cancer with the help of biotechnology. With strong government and federal assistance and recruitment of extremely trained researchers has made it possible for countries such as China and India to swiftly develop capacity for regenerative medication.

Some of the major players operating in this market include Abbott Laboratories, Agilent Technologies, Amgen, BioGen Medical Instruments, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche, Illumina, Merck, PerkinElmer, Qiagen, Thermo Fisher Scientific, Gilead, Celgene, Novo Nordisk A/S, Novartis AG, Sanofi Aventis, and Lonza.

Request For Discount: https://www.polarismarketresearch.com/industry-analysis/biotechnology-market/request-for-discount-pricing

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world

Polaris Market Research

Phone: 1-646-568-9980

Email: [email protected]

Web: www.polarismarketresearch.com

0 notes

industry365 · 3 years

Text

Biotechnology Market Size, Share, Growth and Industry Forecast By 2028

The global biotechnology market is estimated to reach USD 2,267.77 billion by 2028 growing at a CAGR of 15.5% during the forecast period, according to a new study published by Polaris Market Research. The report ‘Biotechnology Market Share, Size, Trends & Industry Analysis Report By Technology (Fermentation, Tissue Engineering and Regeneration, PCR Technology, Nanobiotechnology, Chromatography, DNA Sequencing, Cell Based Assays); By Application; and By Region; Segment Forecast, 2021 – 2028’ provides an extensive analysis of present market dynamics and predicted future trends.

Growing hepatitis B disease, increasing interest in horticultural items such as sugarcane, rice, beans, and wheat due to the increasing populations in economies such as the U.S., China, and India are expected to push the overall biotechnology market.

The growth of this market is further propelled by elements such as deficiency of water, low yield of items, insect attacks, and constrained availability of agrarian land, which is promoting the companies to invest and conduct R&D activities at a broader scale. Another factor that is helping the market growth includes regenerative medicines.

The existence of a huge section of businesses concentrating on the advancement of regenerative treatments is anticipated to push the market development through to 2026. Technological developments in the areas of artificial intelligence are estimated to sustain progress with possible opportunities. The companies are engaged in using artificial intelligence in order to understand cancer cases while working on medical trials.

Encouraging government policies associated with biological advancements is also propelling the demand growth. Established economies such as the U.S. and UK and growing economies such as China and India are investing in biotechnology R&D initiatives. Governments are associating with private companies for expanding their research into this domain.

Download sample: https://www.polarismarketresearch.com/industry-analysis/biotechnology-market/request-for-sample

Owing to technological improvements and prevalent applications of biotechnology in healthcare is helping the market to gain strong growth during the forecast period. Companies are constantly introducing brand-new biotechnological medicines and vaccines to deal with diagnosis and biopharmaceutical development within the healthcare sector, which is approximated to push the market further towards its growth.

Bioinformatics is anticipated to witness the fastest growth in the coming years. Developments in data combination tools through cloud computing platforms facilitate analysis and assistance to process enormous next-generation sequencing information. These advancements are approximated to greatly boost the adoption of bioinformatics tools in numerous life sciences applications in the near future.

The application of nanotechnology-based products is anticipated to improve development in this sector. Reducing costs and increase in the number of services related to biotechnology are expected to drive the growth with profitable avenues.

North American pharma and biotech organizations have experienced excellent success in the last couple of years resulting in a larger revenue share. Universities and research institutes are also introducing various biotech-based programs which would help the industry to gain much-required traction.

The Asia Pacific industry on the other hand is anticipated to grow at the most significant rate due to improving and growing healthcare infrastructure coupled with local companies in this region focusing on developing advanced medicines to cure chronic diseases such as cancer with the help of biotechnology. Strong government and federal assistance and recruitment of extremely trained researchers have made it possible for countries such as China and India to swiftly develop capacity for regenerative medication.

Get discount offer: https://www.polarismarketresearch.com/industry-analysis/biotechnology-market/request-for-discount-pricing

Polaris Market Research has segmented the global biotechnology market on the basis of technology, application, and region:

Biotechnology Technology Outlook (Revenue, USD Billion, 2016 – 2028)

Nanobiotechnology

DNA Sequencing

Tissue regeneration and engineering

Chromatography

PCR technology

Fermentation

Cell-based assays

Others

Biotechnology Application Outlook (Revenue, USD Billion, 2016 – 2028)

BioPharmacy

BioServices

BioAgriculture

BioIndustrial

Bioinformatics

Biotechnology Regional Outlook (Revenue, USD Billion, 2016 – 2028)

North America

Europe

Asia-Pacific

Latin America

Middle East & Africa

U.S.

Canada

Germany

France

Italy

Spain

Netherlands

China

India

Japan

South Korea

Singapore

Malaysia

Thailand

Brazil

Mexico

UAE

Saudi Arabia

South Africa

Buy Now: https://www.polarismarketresearch.com/checkouts/21

#Biotechnology Market Management

0 notes

udaycmi · 3 years

Text

Biotechnology Market Emerging Trends and Interesting Opportunities

Get Sample copy of report: https://www.polarismarketresearch.com/industry-analysis/biotechnology-market/request-for-sample

Request For Discount: https://www.polarismarketresearch.com/industry-analysis/biotechnology-market/request-for-discount-pricing

About Polaris Market Research

Polaris Market Research

Phone: 1-646-568-9980

Email: [email protected]

Web: www.polarismarketresearch.com

0 notes

itssashasharma · 3 years

Text

Bioinformatics Services Market worth USD 5.3 Billion : Technological advancements in the field of Sequencing and Data Analysis

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.

According to the new market research report “Bioinformatics Services Market by Type (Sequencing, Data Analysis, Discovery, Gene Expression, Database Management), Specialty (Medical, Plant, Forensics), Application (Genomics, Metabolomics), Enduser (Academia, Pharma-biotech) – Global Forecast to 2026″, published by MarketsandMarkets™, the global market is projected to reach USD 5.3 Billion by 2026 from USD 2.5 Billion in 2021, at a CAGR of 15.8% during the forecast period.

Browse in-depth TOC on “Bioinformatics Services Market” 203 – Tables 41 – Figures 238 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=75889439

Bioinformatics services have always had huge potential when it comes to providing essential support to many areas of scientific research. The COVID-19 pandemic was a real-life test for bioinformatics. One of the major focus areas for every country during the COVID-19 pandemic has been to study and understand how to halt the progress of the virus. Decoding the genome of the novel coronavirus was a crucial step in developing vaccines and for better understanding the mechanism of the virus and how it functions in the human body. Thus, various studies were undertaken to understand the genetic combination of the virus; these studies were driven by bioinformatics.

The growing applications of bioinformatics across industries, increasing public-private sector funding for bioinformatics services, and the shortage of skilled bioinformatics professionals (leading to increased outsourcing of bioinformatics projects) are the major factors that are expected to drive the growth of the market during the forecast period. However, the in-house development of bioinformatics solutions and publicly available bioinformatics tools are expected to limit market are expected to restrain market growth in the coming years.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=75889439

North America dominated the global bioinformatics services market in 2020

The North American market dominated the market. The growth in North America can be attributed to government initiatives for the reimbursement of genomic testing and favorable funding scenario for research activities.

Browse Adjacent Markets: Healthcare IT Market Research Reports & Consulting

Browse Related Reports:

Genomics Market by Product & Service (System & Software, Consumables, Services), Technology (Sequencing, PCR), Application (Drug Discovery & Development, Diagnostic, Agriculture), End User (Hospital & Clinics, Research Centers) – Global Forecast to 2025 https://www.marketsandmarkets.com/Market-Reports/genomics-market-613.html

NGS-Based RNA-Sequencing Market by Product & Services (Sample Preparation, Platforms & Consumables, Services, Data Analysis), Technology (SBS, SMRT, Nanopore), Application (De Novo, Epigenetics, small RNA), End-User, Region – Global Forecast to 2024 https://www.marketsandmarkets.com/Market-Reports/ngs-based-rna-seq-market-102977816.html

About MarketsandMarkets™

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: [email protected] Research Insight: https://www.marketsandmarkets.com/ResearchInsight/bioinformatic-service-market.asp Visit Our Web Site: https://www.marketsandmarkets.com

#Bioinformatics Services Market

0 notes